In JAK2-V617F transgenic mice, the loss of just a single Hmga1 allele was sufficient to dampen erythrocytosis and thrombocytosis while preventing splenomegaly, osteosclerosis, and myelofibrosis [48]. This evidence concerns the gene JAK2 and thrombocytosis disease.